Resources


Advanced




  This area of the site
   requires the
  Acrobat Reader
  and the ability to
  view zipped files.
  Click below to
  download the
   necessary
   software.
  The StuffIt
   software can be
   used for either
   Windows or
   Macintosh.


Download the Adobe Acrobat reader

Download the StuffIt Expander

Download WinZip

 
 
Slide Lecture Programs
The vascular endothelium and CAD: New target considerations in treating the cardiovascular dysmetabolic syndrome
September 24, 1999

The attached slide materials represent the seventh in a series of slide/lecture programs that focus on what continues to be one of the most exciting new fields of emerging data: The endothelium and its role in cardiovascular health and disease.

These materials extend the knowledge presented in the six previous programs that helped define the endothelium as a mediator of cardiovascular function and structure. Endothelial function is now recognized as critically important in the pathogenesis of atherosclerosis and other cardiovascular conditions that are common in people with diabetes. The endothelium is considerably influenced by components of the cardiovascular dysmetabolic syndrome, including insulin resistance, hypertension and lipids. As our understanding of the pathophysiology of cardiovascular disease is revised, our treatment algorithms should also be updated. This program covers current knowledge concerning the pathophysiology and clinical trials assessing treatments based on this knowledge.

The outline that follows is keyed to the slides. For each slide you will find succinct content points:

View/Download individual slides (120 Slides)
Need Download Help?
  View Thumbnails  Download  Slides
The cardiovascular dysmetabolic syndrome
  PPT   PPT  118 - 120
  Download entire presentation   PPT   PDFPDF All Slides 

This slide/lecture program has been created under the auspices of the Vascular Biology Working Group. The overall goal of this program and future programs is to educate healthcare professionals concerning the modern role of the endothelium as a key to cardiovascular health, and to spur exploration of therapeutic interventions capable of improving endothelial function and thereby help to reduce incidence of adverse outcomes.

Published by Medical Education Consultants, Inc. (MEDCON), on behalf of the University of Florida College of Medicine. Supported by an unrestricted educational grant from Parke-Davis, a Division of Warner-Lambert Company. Copyright © 1999.

The editorial content of this program expresses the views of the individual contributors and does not necessarily reflect the views or recommendations of the University of Florida College of Medicine, Parke-Davis, or the publisher. The indications and dosages of drugs discussed in this program may vary from those approved by the Food and Drug Administration (FDA). The reader is advised to consult the full prescribing information for each medication prior to use.

Home | Literature Update | Journal Link | Resources | Meeting Highlights | Members | About VBWG | Web Links